Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assunta Bianco

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Plos One|July 31, 2019
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray)Alessandro Enrico Grimaldi, Laura De Giglio, Shalom Haggiag, et al.
International Journal of Molecular Sciences|April 27, 2024
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?Assunta Bianco, Gabriele Di Sante, Francesca Colò, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 3, 2021
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapiesFioravante Capone, Matteo Lucchini, Elisabetta Ferraro, et al.
Therapeutic Advances in Neurological Disorders|March 5, 2026
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practiceAurora Zanghì, Giovanna Borriello, Matteo Foschi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 8, 2021
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis PatientsAssunta Bianco, Matteo Lucchini, Rocco Totaro, et al.
Journal of the Neurological Sciences|September 15, 2019
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimodEmilio Vanoli, Nicola Montano, Giuseppe De Angelis, et al.
Journal of Neuroimmunology|October 2, 2007
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosisGiovanni Frisullo, Massimiliano Mirabella, Francesco Angelucci, et al.
European Journal of Neurology|June 19, 2023
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndromeDomenico Plantone, Eleonora Sabatelli, Sara Locci, et al.
Journal of Clinical Immunology|November 11, 2010
CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRIGiovanni Frisullo, Roberto Frusciante, Viviana Nociti, et al.
Biomaterials|December 9, 2022
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patientsMaria Tredicine, Francesco Ria, Noemi Poerio, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Plos One|July 31, 2019
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray)Alessandro Enrico Grimaldi, Laura De Giglio, Shalom Haggiag, et al.
International Journal of Molecular Sciences|April 27, 2024
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?Assunta Bianco, Gabriele Di Sante, Francesca Colò, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 3, 2021
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapiesFioravante Capone, Matteo Lucchini, Elisabetta Ferraro, et al.
Therapeutic Advances in Neurological Disorders|March 5, 2026
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practiceAurora Zanghì, Giovanna Borriello, Matteo Foschi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 8, 2021
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis PatientsAssunta Bianco, Matteo Lucchini, Rocco Totaro, et al.
Journal of the Neurological Sciences|September 15, 2019
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimodEmilio Vanoli, Nicola Montano, Giuseppe De Angelis, et al.
Journal of Neuroimmunology|October 2, 2007
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosisGiovanni Frisullo, Massimiliano Mirabella, Francesco Angelucci, et al.
European Journal of Neurology|June 19, 2023
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndromeDomenico Plantone, Eleonora Sabatelli, Sara Locci, et al.
Journal of Clinical Immunology|November 11, 2010
CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRIGiovanni Frisullo, Roberto Frusciante, Viviana Nociti, et al.
Biomaterials|December 9, 2022
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patientsMaria Tredicine, Francesco Ria, Noemi Poerio, et al.
Pageof 4